Vera Bril

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Richard AC Hughes, Peter D. Donofrio, Vera Bril et al. · The Lancet Neurology · 2008 · 656 citations · Full text

Ice Study, Autoimmune Disease, Chronic Inflammatory +8

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic

Bruce A. Perkins, David O. Olaleye, Bernard Zinman et al. · Diabetes Care · 2001 · 572 citations

Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy

Vera Bril, Bruce A. Perkins · Diabetes Care · 2002 · 449 citations · Full text